216 related articles for article (PubMed ID: 25058372)
21. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H
Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088
[TBL] [Abstract][Full Text] [Related]
22. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
23. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders.
Bain BJ
Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of monocytosis in patients with myeloproliferative disorders.
Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E
Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764
[TBL] [Abstract][Full Text] [Related]
25. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
26. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries.
Polednak AP
J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013
[TBL] [Abstract][Full Text] [Related]
27. Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain.
Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Marcos-Gragera R
Haematologica; 2013 Aug; 98(8):e95-7. PubMed ID: 23812933
[No Abstract] [Full Text] [Related]
28. Ethnic and border differences on blood cancer presentation and outcomes: A Texas population-based study.
Bencomo-Alvarez AE; Gonzalez MA; Rubio AJ; Olivas IM; Lara JJ; Padilla O; Orazi A; Corral J; Philipovskiy A; Gaur S; Mulla ZD; Dwivedi AK; Eiring AM
Cancer; 2021 Apr; 127(7):1068-1079. PubMed ID: 33616915
[TBL] [Abstract][Full Text] [Related]
29. An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults.
Savona MR; Malcovati L; Komrokji R; Tiu RV; Mughal TI; Orazi A; Kiladjian JJ; Padron E; Solary E; Tibes R; Itzykson R; Cazzola M; Mesa R; Maciejewski J; Fenaux P; Garcia-Manero G; Gerds A; Sanz G; Niemeyer CM; Cervantes F; Germing U; Cross NC; List AF;
Blood; 2015 Mar; 125(12):1857-65. PubMed ID: 25624319
[TBL] [Abstract][Full Text] [Related]
30. A case of atypical chronic myeloid leukemia regarded as MDS with myeloproliferative features.
Tohda S; Koyama N; Tanaka M; Kida Y; Murakami N; Nara N
Acta Haematol; 1998; 100(4):191-4. PubMed ID: 9973641
[TBL] [Abstract][Full Text] [Related]
31. Cancer immune therapy for myeloid malignancies: present and future.
Holmström MO; Hasselbalch HC
Semin Immunopathol; 2019 Jan; 41(1):97-109. PubMed ID: 29987478
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study.
Lee KH; Choi SJ; Lee JH; Kim S; Seol M; Lee YS; Kim WK; Lee JS; Lee JH
Bone Marrow Transplant; 2004 Oct; 34(7):627-36. PubMed ID: 15300231
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma.
Duong VH; Holtzman NG; Koka R; Singh ZN; Zou Y; Emadi A; Rapoport AP; Kocoglu MH; Baer MR; Badros AZ
Leuk Lymphoma; 2019 Dec; 60(14):3577-3580. PubMed ID: 31282234
[No Abstract] [Full Text] [Related]
34. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.
Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Zhang W; Yang L; Yan Y; Lin J; Qian J
J Cell Mol Med; 2017 Aug; 21(8):1468-1481. PubMed ID: 28452111
[TBL] [Abstract][Full Text] [Related]
36. Incidence of chronic myeloid leukemia and patient survival: results of five French population-based cancer registries 1980-2009.
Penot A; Preux PM; Le Guyader S; Collignon A; Herry A; Dufour V; Monnereau A; Woronoff AS; Troussard X; Pons E; Bordessoule D; Maynadié M
Leuk Lymphoma; 2015 Jun; 56(6):1771-7. PubMed ID: 25535815
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms.
Patel U; Luthra R; Medeiros LJ; Patel KP
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S62-S74. PubMed ID: 28760304
[TBL] [Abstract][Full Text] [Related]
38. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
[TBL] [Abstract][Full Text] [Related]
39. Incidence and Bayesian Mapping of Myeloid Hematologic Malignancies in Sardinia, Italy.
Broccia G; Carter J; Ozsin-Ozler C; De Matteis S; Cocco P
Cancer Control; 2023; 30():10732748231202906. PubMed ID: 37877513
[TBL] [Abstract][Full Text] [Related]
40. Salvaged single-unit cord blood transplantation for 26 patients with hematologic malignancies not in remission.
Yao W; Zheng CC; Liu HL; Geng LQ; Tang BL; Tong J; Zhu XY; Song KD; Qiang P; Sun ZM
Braz J Med Biol Res; 2015 Oct; 48(10):871-6. PubMed ID: 26445329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
